Tag: trending with impact

Rare Benign Kidney Tumor Case Highlights Value of Biopsy and Minimally Invasive Treatment

July 6, 2026

“Renal oncocytoma is a rare benign kidney tumor arising from the intercalated cells of the distal renal tubules.” BUFFALO, NY - July 6, 2026 – A new case report was… read more

Oncotarget

TRAIL-R2 Silencing Linked to More Aggressive Breast Cancer

June 24, 2026

“TRAIL-R2 is also a key mediator of apoptosis but its clinical implications and epigenetic regulation in breast cancer are not clearly understood.” BUFFALO, NY - June 24, 2026 – A… read more

Oncotarget

Protein Linked to Melanoma Growth May Suppress the Body’s Natural Anti-Tumor Immune Response

June 17, 2026

“However, DHHC3 does control primary melanoma growth by supporting anti-melanoma immunity.” BUFFALO, NY - June 17, 2026 – A new research paper was published in Volume 17 of Oncotarget on… read more

Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer

Oncotarget

Protein in Tumor Microenvironment Found to Promote Colorectal Cancer Growth and Immune Evasion

June 2, 2026

“These results identify CTHRC1 as a key driver of CRC that may suppress the immune system, allowing for easier immune evasion by tumor cells, highlighting CTHRC1 as a potential new… read more

Oncotarget

Rare Laryngeal Leiomyosarcoma Successfully Treated with Surgery and Adjuvant Chemotherapy

May 13, 2026

“Laryngeal leiomyosarcoma (LLMS) is an exceptionally rare malignant tumor, accounting for less than 1 % of all laryngeal cancers, which are predominantly epithelial in origin.” BUFFALO, NY - May 13,… read more

Oncotarget

Rare Dual-Mutation GIST Responds to Targeted Therapy, Challenging Established Tumor Biology

May 6, 2026

“Gastrointestinal stromal tumors (GISTs) are molecularly defined by oncogenic alterations that predict clinical behavior and response to therapy.” BUFFALO, NY - May 6, 2026 – A new case report was… read more